Bespoke Extracts, Inc. SEC 10-Q Report

Bespoke Extracts, Inc., a company specializing in the production and sale of cannabis products, has released its Form 10-Q report for the third quarter ended September 30, 2025. The report highlights significant improvements in both financial and operational performance, driven by increased sales and enhanced production efficiencies.

Financial Highlights

Sales: Bespoke Extracts reported sales of $467,945 for the three months ended September 30, 2025, a substantial increase from $277,471 for the same period in 2024. This growth was primarily driven by higher product sales of pre-rolled joints and increased joint production services for third parties.

Gross Profit: The company's gross profit for the three months ended September 30, 2025, was $234,175, compared to $114,995 for the same period in 2024. The improvement reflects increased efficiencies alongside revenue growth.

Loss from Operations: Bespoke Extracts reduced its loss from operations to $(53,891) for the three months ended September 30, 2025, from $(262,468) for the same period in 2024. The reduction in loss is attributed to decreased stock-based compensation and general legal fees.

Net Loss: The company reported a net loss of $(78,088) for the three months ended September 30, 2025, compared to $(275,613) for the same period in 2024. The decrease in net loss is due to increased sales and reduced operating expenses.

Net Loss Per Common Share Outstanding: The net loss per common share was $(0.01) for the three months ended September 30, 2025, compared to $(0.03) for the same period in 2024.

Business Highlights

Revenue Segments: The company experienced an increase in sales of pre-rolled joints to licensed dispensaries in Colorado, as well as increased joint production services for third parties. This growth was driven by new product offerings and an increase in sales of Fresh Joint products.

Geographical Performance: All of the company's net sales for the reporting period were generated in North America, specifically in the State of Colorado, indicating a focused regional market presence.

Sales Units: The increase in sales was attributed to higher production volumes of pre-rolled joints, which were sold to licensed dispensaries and through joint production services for third parties.

New Product Launches: The company introduced new products in the pre-rolled joint category, which contributed to the increase in sales and market penetration.

Operational Efficiency: Bespoke Extracts achieved a decrease in cost of goods sold as a percentage of sales, primarily due to increased efficiencies in production and revenue growth.

Future Outlook: The company plans to expand its focus to regulated cannabis markets in the United States, leveraging its existing operations in Colorado to explore new opportunities and enhance its market presence.

SEC Filing: Bespoke Extracts, Inc. [ BSPK ] - 10-Q - Nov. 12, 2025